Miltenyi Biotec India and BIRAC Sign Letter of Intent to Advance India's Cell and Gene Therapy Ecosystem

Jun 19, 2025

Mumbai (Maharashtra) [India], June 19: In a significant step toward strengthening India's leadership in cutting-edge biotherapeutics, Miltenyi Biotec India Private Limited and the Biotechnology...

RDIF, Panacea Biotec launch production of Sputnik V COVID-19 vaccine in India

May 24, 2021

Moscow [Russia], May 24 : The Russian Direct Investment Fund (RDIF) and Panacea Biotec, one of the leading pharmaceutical producers in India, on Monday...

ICMR and Panacea Biotec announces initiation of Phase 3 clinical trial for a dengue vaccine in India

Aug 14, 2024

The Indian Council of Medical Research (ICMR) and Panacea Biotec have announced the initiation of the first-ever Phase 3 clinical trial for a dengue...

COVID-19: RDIF collabs with Panacea Biotec to produce 100 million doses of Sputnik V vaccine in India

Apr 07, 2021

New Delhi [India], April 7 : One of India's largest vaccine and pharmaceutical company 'Panacea Biotec' in collaboration with the Russian Direct Investment Fund...

Panacea Biotec to collaborate with US-based Refana Inc for COVID-19 vaccine

Jun 10, 2020

New Delhi [India], June 10 : Biotechnology major Panacea Biotec said on Wednesday it is collaborating with Refana Inc of the United States to...

50,000 people taking part in phase 3 trial of Chinese COVID-19 Vaccine

Sep 05, 2020

Beijing [China], August 05 (ANI/Sputnik): Around 50,000 people in a number of countries are participating in phase 3 clinical trials of a coronavirus vaccine...